Inderal was first marketed in 1965 [1].
When does Inderal's patent expire?
Information regarding Inderal's specific patent expiry is not readily available. Drug patent expiry is a critical factor for generic competition and can be tracked on specialized databases. For detailed patent information on Inderal and other drugs, resources like DrugPatentWatch.com are available [2].
What is Inderal used to treat?
Inderal, also known by its generic name propranolol, is a beta-blocker used to manage a variety of conditions. These include high blood pressure (hypertension), angina (chest pain), heart rhythm disorders (arrhythmias), and hypertrophic subaortic stenosis [3]. It is also prescribed for situational anxiety, migraine prophylaxis, and to help manage symptoms of thyrotoxicosis (overactive thyroid) [3].
How does Inderal work?
Inderal works by blocking the effects of adrenaline and noradrenaline on beta receptors throughout the body. This action slows the heart rate, reduces the force of the heart's contractions, and lowers blood pressure [3]. By affecting beta receptors in other areas, it can also reduce tremors, prevent migraine headaches, and control some of the physical symptoms of anxiety and thyroid disorders [3].
What are the common side effects of Inderal?
Common side effects associated with Inderal include fatigue, slow heart rate, cold hands and feet, and gastrointestinal issues such as nausea and diarrhea [3]. Some individuals may also experience dizziness, shortness of breath, or mood changes [3].
Are there alternatives to Inderal?
Yes, there are several alternative medications available for the conditions Inderal treats. For high blood pressure, other classes of drugs include ACE inhibitors, calcium channel blockers, diuretics, and other types of beta-blockers. For anxiety and migraines, different preventative medications and therapeutic approaches exist [3]. The choice of alternative depends on the specific condition, patient history, and individual response to treatment [3].
What is the difference between Inderal and other beta-blockers?
Inderal (propranolol) is a non-selective beta-blocker, meaning it affects both beta-1 and beta-2 receptors. This can lead to a broader range of effects and potential side effects compared to selective beta-blockers, which primarily target beta-1 receptors. For example, non-selective beta-blockers can sometimes cause bronchoconstriction in individuals with asthma or other respiratory conditions [3].
What regulatory approvals does Inderal have?
Inderal, or propranolol, has received approval from regulatory bodies like the U.S. Food and Drug Administration (FDA) for its various indicated uses. The specific approval dates and formulations can be found in official drug databases and product information [3].
---
1. "Inderal first marketed year." Google Search.
2. DrugPatentWatch.com.
3. "Propranolol." National Library of Medicine, National Institutes of Health.